http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008231062-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021bf9e4fb6f327fd320976eb0b139c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9cb29d77c9d38ea34786b213402555
publicationDate 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008231062-A
titleOfInvention Manufacturing method of mirtazapine
abstract [PROBLEMS] To provide mirtazapine which can be safely used as a pharmaceutical product with high purity from a reaction solution obtained by cyclizing 2- (4-methyl-2-phenylpiperazin-1-yl) pyridine-3-methanol with concentrated sulfuric acid by a simple method. A method of isolation is provided. A reaction solution obtained by cyclization of 2- (4-methyl-2-phenylpiperazin-1-yl) pyridine-3-methanol with concentrated sulfuric acid is diluted with water and then made alkaline in the presence of propanol. A method for producing mirtazapine, comprising extracting mirtazapine with propanol and then crystallizing mirtazapine from the extract. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020007243-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017088564-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7018840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017088565-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017039659-A
priorityDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0138330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0138329-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004500324-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227547528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450423205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10221435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454356204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22263336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426156635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21702714

Total number of triples: 42.